Global C-reactive Protein Testing Market

Global C-reactive Protein Testing Market size was valued at US$ 1.66 Bn. in 2022 and the total revenue is expected to grow at CAGR 1.5% through 2023 to 2029, reaching nearly US$ 1.85 Bn.

C-reactive Protein Testing Market Overview:

C-reactive Protein Test is a blood tear that measures the level of C- reactive protein. This test identifies different types of infection and diseases that cause inflammation such as Cancer, Cardiovascular disease, Arthritis, etc. C-reactive Protein Test can estimate the risk of a person suffering from heart attack and stroke. Advancements in Nanotechnological tools are expected to provide a lucrative perspective in designing portable bioanalytical assays with high specificity and sensitivity, faster response time, and multiplexing capabilities for onsite accurate disease diagnosis and monitoring. As increasing chronic disease among the population, the demand for this test is increasing.To know about the Research Methodology :- Request Free Sample Report

C-reactive Protein Testing Market Dynamics:

With increasing cases of Cardiovascular disorder across the globe and research and development to update the C-reactive Protein Testing methods, these are the major factors to grow the C-reactive Protein Testing market. AS per the research conducted by American Heart Association (AHA) in 2019, Cardiovascular disorder results in more than 801,000 deaths in the US, and nearly 2,200 patients have died because of Cardiovascular disorder.

In addition, the growing elderly population coupled with rising cases of diabetes mellitus are also driving the C-reactive Protein Testing market. Gastrointestinal diseases coupled with subsequent demand for robust disease testing protocols has driven the market National Institute of Health and Care Excellence has recommended the usage of POC CRP testing in primary care of adult patients diagnosed with respiratory tract infection.

Initiatives undertaken by government agencies to increase awareness as well as uptake of point of care are factors driving the market. Increase in funds and investments for research entities that are engaged in performing research activities in the area, boost, and market progression. According to the World Heart Federation, coronary heart disease is the leading cause of death worldwide. An estimated 3.8 million men and 3.4 million women die each year from coronary heart disease. Plasmonic Nanoparticles (PNPs) are among the tools that can be used for biosensing applications owing to their versatile optical properties. Aidan offers easy-to-use Quickread go CRP tests and a portable QuikRead go instrument for quantitative measurement of C-reactive protein. Companies such as Abbott and Aidian offer products that can be used as supportive diagnostic tools in the management of COVID-19 infection.

C-reactive Protein Testing Market Segment Analysis:

Based on the Assay Type, The C-reactive Protein Testing Market is segmented into Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others. The ELISA segment is sub-segmented into the Clinical and Non-Clinical. The Immunoturbidimetric Assay segment dominated the market and held the largest market share of 48.5% in the year 2022. This segment is anticipated to grow further with the highest CAGR during the forecast period. The application of this technique in several chronic disorders of the cardiac and respiratory systems is expected to dominate this segment by the end of 2029. Development in the Chemiluminescence Immunoassay technique to provide accurate results is expected to propel the market growth by driving the segment.Based on the Application, The C - reactive protein Testing Market is segmented into Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Endometriosis. The cardiovascular Diseases segment dominated the market with the largest market share of 21.8% in the year 2022. An increase in the prevalence of CVDs is the major factor contributing to the growth of the market. Adoption of a sedentary lifestyle, obesity, hypertension, and diabetes are a few risk factors associated with CVDs. The Cancer segment held the second-largest market share in the year 2022. According to WHO, there are 1.9 Mn. deaths and 3.7 Mn. new cancer cases every year in the European region. Hence, there is a need for large-scale adoption of POC CRP testing solutions.

Based on the End User, The C-reactive Protein Testing Market is segmented into Hospitals, Clinics, and Diagnostics Labs. The Diagnostics Labs segment dominated the market and is expected to grow with the highest CAGR during the forecast period. C-reactive Protein Testing is used for diagnosis purposes only to recognize the disease condition and infection in the individual. This segment held a market share of 27.4% in the year 2022. Hospitals are the second largest segment and dominated the market during the forecast period.

Regional Insights:

North America dominated the C-reactive Protein Testing Market with the largest market share of 41.4 % in 2022. It is also expected to register at a CAGR of 8.6% during the forecast period. A rise in geriatric population is a key factor responsible for market growth. According to population predictions from the United States Census Bureau, the number of Americans aged 65 and more will increase to approximately 95 Mn. by 2060, up from 52 Mn. in 2019.

Furthermore, the total share of people aged 65 and up is expected to climb from 16% to 23% during the forecast period. The market is being driven by rising healthcare expenditure and the adoption of modern healthcare facilities. For example, according to CMS. gov, healthcare spending in the United States increased by 4.6 percent in 2019, reaching USD 3.8 Tr. per person, accounting for 17.7 percent of the country's GDP. Furthermore, favorable reimbursement policies for emergency and non-emergency medical services in the United States and Canada are expected to contribute to market growth.

China and India are the main drivers of the Asia Pacific regional market. Japan, South Korea, and Australia are three of the most populous countries in the world. The growth of the market in this region is being fueled by an increase in the number of hospitals and an increase in hospital admissions for emergency care. Furthermore, an increase in the number of road traffic accidents, resulting in an increase in the patient population, is a major driver of market expansion.

The objective of the report is to present a comprehensive analysis of the C-reactive Protein Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also helps in understanding the C-reactive Protein Testing Market dynamic, structure by analyzing the market segments and project the C-reactive Protein Testing Market size. Clear representation of competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence in the C-reactive Protein Testing Market make the report investor’s guide.

C-reactive Protein Testing Market Scope: Inquire before buying

C-reactive Protein Testing Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

C-reactive Protein Testing Market, Major Key Players

1. Thermo Fisher Scientific, inc.
2. F. Hoffmann-La Roche Ltd.
3. Danaher
4. Quest Diagnostics
5. Siemens Healthineers AG
6. Abbott
7. Merck KGaAA
8. Zoetis
9. Ortho Clinical Diagnostics
10. Getein Biotech, Inc.
11. HORIBA, Ltd
12. Randox Laboratories Ltd.
13. BODITECH MED, INC.
14. Aidian

Frequently Asked Questions:

1] Which segments are covered in C-reactive Protein Testing Market report?
Ans. The segments covered in market report are By Assay Type, By Application and End Users.

2] Which region is expected to hold the highest share in the Hospital Stretchers Market?
Ans. North America is expected to hold the highest share in the market

3] What is the market size of C-reactive Protein Testing Market by 2029?
Ans. The market size of market by 2029 is US $ 1.85 Bn.

4] Who are the top key players in the Hospital Stretchers Market?
Ans Thermo Fisher Scientific, inc., F. Hoffmann-La Roche Ltd., Danaher, Quest, Diagnostics, Siemens Healthineers AG, Abbott, Merck KGaAA, Zoetis, Ortho Clinical Diagnostics, Getein Biotech, Inc., HORIBA, Ltd, Randox Laboratories Ltd.

5] What was the market size of C-reactive Protein Testing Market in 2022?
Ans. The market size of market in 2022 was US $ 1.66 Bn.